10.78
price down icon0.28%   -0.03
after-market Dopo l'orario di chiusura: 10.45 -0.33 -3.06%
loading
Precedente Chiudi:
$10.81
Aprire:
$10.78
Volume 24 ore:
188.43K
Relative Volume:
0.58
Capitalizzazione di mercato:
$572.31M
Reddito:
-
Utile/perdita netta:
$-83.74M
Rapporto P/E:
-6.6957
EPS:
-1.61
Flusso di cassa netto:
$-64.98M
1 W Prestazione:
-0.74%
1M Prestazione:
+10.68%
6M Prestazione:
-32.12%
1 anno Prestazione:
-48.62%
Intervallo 1D:
Value
$10.63
$11.11
Intervallo di 1 settimana:
Value
$10.08
$11.19
Portata 52W:
Value
$6.42
$29.60

Tyra Biosciences Inc Stock (TYRA) Company Profile

Name
Nome
Tyra Biosciences Inc
Name
Telefono
(619) 728-4760
Name
Indirizzo
2656 STATE STREET, CARLSBAD
Name
Dipendente
60
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
TYRA's Discussions on Twitter

Confronta TYRA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TYRA
Tyra Biosciences Inc
10.78 547.20M 0 -83.74M -64.98M -1.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-21 Ripresa Piper Sandler Overweight
2025-01-07 Iniziato UBS Buy
2024-10-18 Aggiornamento BofA Securities Neutral → Buy
2024-08-15 Iniziato Piper Sandler Overweight
2023-12-15 Downgrade BofA Securities Buy → Neutral
2023-06-30 Iniziato Wedbush Outperform
2023-02-03 Iniziato Oppenheimer Outperform
2022-06-23 Iniziato H.C. Wainwright Buy
2022-03-08 Aggiornamento Jefferies Hold → Buy
2021-11-08 Downgrade Jefferies Buy → Hold
2021-10-11 Iniziato BofA Securities Buy
2021-10-11 Iniziato Cowen Outperform
2021-10-11 Iniziato Jefferies Buy
Mostra tutto

Tyra Biosciences Inc Borsa (TYRA) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about Tyra Biosciences Inc. stockHigh-octane gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Tyra Biosciences (NASDAQ:TYRA) Trading Down 3% – Here’s Why - Defense World

Jul 23, 2025
pulisher
Jul 23, 2025

Tyra Biosciences Inc. Stock Analysis and ForecastRecord-setting profit potential - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Tyra Biosciences Inc. stock priceExponential return rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Tyra Biosciences Inc. a good long term investmentRemarkable growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Tyra Biosciences Inc. stock attracts strong analyst attentionHigh Yield Opportunities - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Achondroplasia Breakthrough? Tyra Biosciences CEO Reveals Latest Treatment Progress at UBS Fireside Chat - Stock Titan

Jul 21, 2025
pulisher
Jul 21, 2025

June Brings on Some Huge Insider Buying - AOL.com

Jul 21, 2025
pulisher
Jul 18, 2025

What analysts say about HOOK stockPhenomenal capital appreciation - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Trading (TYRA) With Integrated Risk Controls - news.stocktradersdaily.com

Jul 18, 2025
pulisher
Jul 18, 2025

What drives Diana Shipping Inc. stock priceSuperior profit margins - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

What drives Third Harmonic Bio Inc. stock priceOutstanding risk-reward balance - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 16, 2025

Tyra Biosciences Rises On Precision Medicine Hopes And Analyst Support - Finimize

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Tyra Biosciences Inc. stock price move sharplySmart Return Focused Trading - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Tyra Biosciences Inc. stock performs during market volatilityInsider Strategy Insight - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Tyra Biosciences Insider Lowered Holding By 58% During Last Year - simplywall.st

Jul 15, 2025
pulisher
Jul 14, 2025

Advanced Urothelial Carcinoma Clinical Trials 2025: EMA, PDMA, - openPR.com

Jul 14, 2025
pulisher
Jul 13, 2025

Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛

Jul 13, 2025
pulisher
Jul 09, 2025

Tyra Biosciences Announces Late-Breaking Poster Presentation on TYRA-300 Preclinical Results at ENDO 2025 - Eastern Progress

Jul 09, 2025
pulisher
Jul 09, 2025

Tyra Biosciences' TYRA-300 Emerges as Dual-Threat Therapy, Poised to Drive Clinical and Market Momentum - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

New TYRA-300 Preclinical Data Reveals Promising Results for Rare Bone Growth Disorder Treatment - Stock Titan

Jul 08, 2025
pulisher
Jul 08, 2025

Where are the Opportunities in (TYRA) - news.stocktradersdaily.com

Jul 08, 2025
pulisher
Jul 02, 2025

Tyra Biosciences’ (TYRA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Jul 02, 2025
pulisher
Jul 01, 2025

TYRA-300 Begins Phase 2 Trial in FGFR3-Altered NMIBC - Targeted Oncology

Jul 01, 2025
pulisher
Jun 30, 2025

Tyra Biosciences Doses First Patient in Phase 2 Study of TYRA-300 in Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302) - Longview News-Journal

Jun 30, 2025
pulisher
Jun 30, 2025

Tyra Biosciences, Inc.(NasdaqGS: TYRA) added to Russell 2000 Value Index - MarketScreener

Jun 30, 2025

Tyra Biosciences Inc Azioni (TYRA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):